[Form 4] Sigmatron International Inc Insider Trading Activity

Rhea-AI Filing Summary

Gilead Sciences Inc. (GILD) – Form 144 filing: CEO Daniel O’Day has filed a notice to sell up to 10,000 shares of Gilead common stock through broker Morgan Stanley on or about 28 Jul 2025. The proposed sale has an aggregate market value of $1.14 million, implying a reference price of roughly $113.94 per share. The shares derive from performance stock granted 24 Jan 2023. Gilead reports 1.24 billion shares outstanding, so the planned sale represents less than 0.001% of the float.

Form 144 also discloses that O’Day sold 20,000 shares during the prior three months—10,000 on 30 Jun 2025 for $1.10 million and 10,000 on 30 May 2025 for $1.10 million. All sales are made under Rule 144; O’Day attests he possesses no undisclosed material adverse information about the company.

The filing signals continued but modest insider selling by the CEO; the dollar amounts are immaterial to Gilead’s capitalization yet may inform sentiment on insider confidence.

Positive

• None.

Negative

• Continued insider selling by the CEO may be perceived negatively by some investors, even though the volumes are small.

Insights

Equity Analyst

TL;DR: Small CEO Rule 144 sale; negligible dilution but may dent sentiment.

The 10 k-share sale (<~$1.1 m) is routine relative to Gilead’s 1.24 bn shares outstanding and follows two similar monthly sales. Insider selling by a CEO can raise eyebrows, yet the volume is immaterial (<0.001% of float) and stems from vested performance stock. No earnings or guidance data change. Unless sales accelerate or cluster before significant events, impact on valuation should be minimal. I view the disclosure as neutral.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

X

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

MANTIA BRUCE J

(Last) (First) (Middle)

C/O SIGMATRON INTERNATIONAL INC.

2201 LANDMEIER RD

(Street)

ELK GROVE VILLAGE IL 60007

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SIGMATRON INTERNATIONAL INC [ SGMA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/25/2025		U		36,500(1)	D	$3.02	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Disposed of pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 20, 2025, by and among SigmaTron International, Inc. (the "Company"), Transom Axis AcquireCo, LLC ("Parent") and Transom Axis MergerSub, Inc. ("Merger Sub"). Pursuant to the Merger Agreement, Parent and MergerSub launched a tender offer (the "Offer") for all outstanding shares of common stock of the Company (the "Shares") for an offer price of $3.02 per share in cash, without interest and less any required tax withholding (the "Offer Consideration"). On July 25, 2025 (the "Acceptance Time"), Merger Sub accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer as of the Acceptance Time, including the Shares tendered by the reporting person, in exchange for the Offer Consideration.

Remarks:

Exhibit 24.1 - Power of Attorney

	/s/ Gary R. Fairhead, as Attorney-in-Fact for Bruce Mantia	07/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many GILD shares is the CEO planning to sell under this Form 144?

Daniel O’Day intends to sell 10,000 Gilead common shares.

What is the estimated value of the planned Gilead stock sale?

The aggregate market value disclosed is $1,139,369.

When is the approximate sale date for the Form 144 shares?

The filing lists an approximate sale date of 28 Jul 2025.

How many GILD shares has the CEO sold in the past three months?

According to the filing, he sold 20,000 shares: 10,000 on 30 Jun 2025 and 10,000 on 30 May 2025.

What percentage of Gilead’s outstanding shares does this sale represent?

The 10,000-share sale equals less than 0.001% of the 1.24 billion shares outstanding.